Showing results (271-280 of 282) with videos related to

Sort By:
Pageof 29
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Cancer Medicine|August 20, 2024
Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genesAnders Berglund, Kosj Yamoah, Steven A Eschrich, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
A catalog of associations between rare coding variants and COVID-19 outcomesJ A Kosmicki, J E Horowitz, N Banerjee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 29